Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription Articles published in Infect Immun Retrieve available abstracts of 55 articles: HTML format Text format

Single Articles

July 2019
1. NARITA K, Hu DL, Asano K, Nakane A, et al
   IL-10 produced by mutant toxic shock syndrome toxin-1 vaccine-induced memory T cells downregulates IL-17 production and abrogates the protective effect against Staphylococcus aureus infection.
   Infect Immun. 2019 Jul 29. pii: IAI.00494-19. doi: 10.1128/IAI.00494.
   PubMed     Text format     Abstract available
   
   
   
2. SINGH AK, Curtiss R 3rd, Sun W
   A recombinant attenuated Yersinia pseudotuberculosis vaccine delivering a Y. pestis YopENt138-LcrV fusion elicits broad protection in mice against plague and yersiniosis.
   Infect Immun. 2019 Jul 22. pii: IAI.00296-19. doi: 10.1128/IAI.00296.
   PubMed     Text format     Abstract available
   
   
   
3. ROWE HM, Mann B, Iverson A, Poole A, et al
   A Cross-reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-mediated Acute Otitis Media.
   Infect Immun. 2019 Jul 15. pii: IAI.00253-19. doi: 10.1128/IAI.00253.
   PubMed     Text format     Abstract available
   
   
   
4. CHAWLA B, Mahajan B, Oakley M, Majam VF, et al
   Antibody-dependent IFN-gamma-independent sterilizing immunity, induced by a subunit malaria vaccine.
   Infect Immun. 2019 Jul 15. pii: IAI.00236-19. doi: 10.1128/IAI.00236.
   PubMed     Text format     Abstract available
   
   
   June 2019
5. HANSON WG, Benanti EL, Lemmens EE, Liu W, et al
   A potent and effective suicidal Listeria vaccine platform.
   Infect Immun. 2019 Jun 24. pii: IAI.00144-19. doi: 10.1128/IAI.00144.
   PubMed     Text format     Abstract available
   
   
   
6. LOUIS L, Clark M, Wise MC, Glennie N, et al
   Intradermal synDNA vaccination generates Leishmania specific T cells in the skin and protection against Leishmania major.
   Infect Immun. 2019 Jun 10. pii: IAI.00227-19. doi: 10.1128/IAI.00227.
   PubMed     Text format     Abstract available
   
   
   May 2019
7. WINTER K, Xing L, Kassardjian A, Ward BJ, et al
   Vaccination against Clostridium difficile using an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge.
   Infect Immun. 2019 May 28. pii: IAI.00089-19. doi: 10.1128/IAI.00089.
   PubMed     Text format     Abstract available
   
   
   
8. BLAND SJ, Larabee JL, Shadid TM, Lang ML, et al
   Deletion of a 19-amino acid region in Clostridioides difficile TcdB2 results in spontaneous autoprocessing, reduced cell binding, and provides a non-toxic immunogen for vaccination.
   Infect Immun. 2019 May 28. pii: IAI.00210-19. doi: 10.1128/IAI.00210.
   PubMed     Text format     Abstract available
   
   
   
9. YSEBAERT C, Denoel P, Weynants V, Bakaletz LO, et al
   A Protein E-PilA fusion protein shows vaccine potential against nontypeable Haemophilus influenzae in mice and chinchillas.
   Infect Immun. 2019 May 20. pii: IAI.00345-19. doi: 10.1128/IAI.00345.
   PubMed     Text format     Abstract available
   
   
   
10. BLAIS N, Somers D, Faubert D, Labbe S, et al
    Design and characterization of PE-PilA, a candidate fusion antigen for non-typeable Haemophilus influenzae vaccine.
    Infect Immun. 2019 May 13. pii: IAI.00022-19. doi: 10.1128/IAI.00022.
    PubMed     Text format     Abstract available
    
    
    April 2019
11. LEDUC I, Fortney KR, Janowicz DM, Zwickl B, et al
    A class I Haemophilus ducreyi strain containing a class II hgbA allele is partially attenuated in humans: implications for HgbA vaccine efficacy trials.
    Infect Immun. 2019 Apr 29. pii: IAI.00112-19. doi: 10.1128/IAI.00112.
    PubMed     Text format     Abstract available
    
    
    
12. DAVIDS BJ, Liu CM, Hanson EM, Le C, et al
    Identification of conserved candidate vaccine antigens in the surface proteome of Giardia lamblia.
    Infect Immun. 2019 Apr 8. pii: IAI.00219-19. doi: 10.1128/IAI.00219.
    PubMed     Text format     Abstract available
    
    
    
13. ACQUAH FK, Adjah J, Williamson KC, Amoah LE, et al
    Transmission-blocking vaccines: old friends and new prospects.
    Infect Immun. 2019 Apr 8. pii: IAI.00775-18. doi: 10.1128/IAI.00775.
    PubMed     Text format     Abstract available
    
    
    
14. KHALAF OH, Chaki SP, Garcia-Gonzalez DG, Ficht TA, et al
    NOD-scid IL2rgamma(null) Mouse Model is suitable to Study Osteoarticular Brucellosis and Vaccine Safety.
    Infect Immun. 2019 Apr 1. pii: IAI.00901-18. doi: 10.1128/IAI.00901.
    PubMed     Text format     Abstract available
    
    
    
15. YOUNG PG, Raynes JM, Loh JM, Proft T, et al
    Group A Streptococcus T-antigens have a highly conserved structure concealed under a heterogeneous surface that has implications for vaccine design.
    Infect Immun. 2019 Apr 1. pii: IAI.00205-19. doi: 10.1128/IAI.00205.
    PubMed     Text format     Abstract available
    
    
    March 2019
16. BEAUDET J, Tulman ER, Pflaum K, Canter JA, et al
    Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.
    Infect Immun. 2019;87.
    PubMed     Text format     Abstract available
    
    
    February 2019
17. ALHASSAN A, Liu H, McGill J, Cerezo A, et al
    Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.
    Infect Immun. 2019;87.
    PubMed     Text format     Abstract available
    
    
    January 2019
18. POOLE ST, Maciel M Jr, Dinadayala P, Dori KE, et al
    Biochemical and immunological evaluation of recombinant CS6-derived subunit enterotoxigenic Escherichia coli vaccine candidates.
    Infect Immun. 2019 Jan 2. pii: IAI.00788-18. doi: 10.1128/IAI.00788.
    PubMed     Text format     Abstract available
    
    
    December 2018
19. CHAN WY, Entwisle C, Ercoli G, Ramos-Sevillano E, et al
    A novel, multiple-antigen pneumococcal vaccine protects against lethal Streptococcus pneumoniae challenge.
    Infect Immun. 2018 Dec 10. pii: IAI.00846-18. doi: 10.1128/IAI.00846.
    PubMed     Text format     Abstract available
    
    
    
20. ROLLENHAGEN JE, Jones F, Hall E, Maves R, et al
    Establishment, validation and application of a New World Primate model of ETEC disease for vaccine development.
    Infect Immun. 2018 Dec 3. pii: IAI.00634-18. doi: 10.1128/IAI.00634.
    PubMed     Text format     Abstract available
    
    
    November 2018
21. TULLIUS MV, Nava S, Horwitz MA
    PPE37 is essential for Mycobacterium tuberculosis heme-iron acquisition (HIA) and a defective PPE37 in Mycobacterium bovis BCG prevents HIA.
    Infect Immun. 2018 Nov 19. pii: IAI.00540-18. doi: 10.1128/IAI.00540.
    PubMed     Text format     Abstract available
    
    
    
22. WANG Y, Wang S, Bouillaut L, Li C, et al
    Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    September 2018
23. HIGGINSON EE, Ramachandran G, Panda A, Shipley ST, et al
    Improved tolerability of a Salmonella Typhimurium live-attenuated vaccine strain by balancing inflammatory potential with immunogenicity.
    Infect Immun. 2018 Sep 24. pii: IAI.00440-18. doi: 10.1128/IAI.00440.
    PubMed     Text format     Abstract available
    
    
    
24. CHANDLER CE, Harberts EM, Laemmermann T, Zeng Q, et al
    In Vivo Intradermal Delivery of Bacteria by Using Microneedle Arrays.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    
25. LIN YH, Chen Y, Smith TC 2nd, Karna SLR, et al
    Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    August 2018
26. LU YJ, Oliver E, Zhang F, Pope C, et al
    Screening for Th17-dependent pneumococcal vaccine antigens: comparison of murine and human cellular immune responses.
    Infect Immun. 2018 Aug 27. pii: IAI.00490-18. doi: 10.1128/IAI.00490.
    PubMed     Text format     Abstract available
    
    
    
27. MANI R, Gupta M, Malik A, Tandon R, et al
    Adjuvant Potential of Poly-alpha-L-glutamine from Cell Wall of Mycobacterium tuberculosis.
    Infect Immun. 2018 Aug 13. pii: IAI.00537-18. doi: 10.1128/IAI.00537.
    PubMed     Text format     Abstract available
    
    
    
28. BATOOL M, Caoili SEC, Dangott LJ, Gerasimov E, et al
    Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    
29. GIUNTINI S, Stoppato M, Sedic M, Ejemel M, et al
    Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    July 2018
30. BOEHM DT, Hall JM, Wong TY, DiVenere A, et al
    Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines using a Bordetella pertussis challenge model in mice.
    Infect Immun. 2018 Jul 16. pii: IAI.00857-17. doi: 10.1128/IAI.00857.
    PubMed     Text format     Abstract available
    
    
    
31. ATCHESON E, Bauza K, Salman AM, Alves E, et al
    Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors.
    Infect Immun. 2018 Jul 9. pii: IAI.00114-18. doi: 10.1128/IAI.00114.
    PubMed     Text format     Abstract available
    
    
    
32. BELDE V, Cravens M, Gulandijany D, Walker JA, et al
    Terminal deoxynucleotidyl Transferase is not required for antibody response to polysaccharide vaccines against Streptococcus pneumoniae and Salmonella Typhi.
    Infect Immun. 2018 Jul 2. pii: IAI.00211-18. doi: 10.1128/IAI.00211.
    PubMed     Text format     Abstract available
    
    
    June 2018
33. KENNEDY SC, Johnson AJ, Bharrhan S, Lindestam Arlehamn CS, et al
    Identification of mycobacterial ribosomal proteins as targets for CD4(+) T cells that enhance protective immunity in tuberculosis.
    Infect Immun. 2018 Jun 11. pii: IAI.00009-18. doi: 10.1128/IAI.00009.
    PubMed     Text format     Abstract available
    
    
    
34. WANG Y, Wen Z, Pan X, Briles DE, et al
    Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
    Infect Immun. 2018 Jun 11. pii: IAI.00423-18. doi: 10.1128/IAI.00423.
    PubMed     Text format     Abstract available
    
    
    
35. PELTON SI
    Deconstructing Pneumococcal Progression from Colonization to Disease.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    
36. ACQUAYE-SEEDAH E, Reczek EE, Russell HH, DiVenere AM, et al
    Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    
37. JENNINGS-GEE J, Quataert S, Ganguly T, D'Agostino R Jr, et al
    The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    May 2018
38. MOFFITT K, Cheung E, Manis J, Malley R, et al
    Evaluation of the Role of stat3 in Antibody and TH17-Mediated Responses to Pneumococcal Immunization and Infection by Use of a Mouse Model of Autosomal Dominant Hyper-IgE Syndrome.
    Infect Immun. 2018;86.
    PubMed     Text format     Abstract available
    
    
    April 2018
39. STYLIANOU E, Harrington-Kandt R, Beglov J, Bull N, et al
    Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine.
    Infect Immun. 2018 Apr 16. pii: IAI.00014-18. doi: 10.1128/IAI.00014.
    PubMed     Text format     Abstract available
    
    
    
40. QUEMENEUR L, Petiot N, Arnaud-Barbe N, Hessler C, et al
    Clostridium difficile toxoid vaccine candidate confers broad protection against a range of prevalent circulating strains in a non-clinical setting.
    Infect Immun. 2018 Apr 9. pii: IAI.00742-17. doi: 10.1128/IAI.00742.
    PubMed     Text format     Abstract available
    
    
    
41. YU J, Li B, Chen X, Lu J, et al
    Comparison of immunogenicity and protection of two pneumococal protein vaccines based on PsaA and PspA.
    Infect Immun. 2018 Apr 2. pii: IAI.00916-17. doi: 10.1128/IAI.00916.
    PubMed     Text format     Abstract available
    
    
    March 2018
42. SERRADELL MC, Gargantini PR, Saura A, Oms SR, et al
    Cytokines, antibodies and histopathological profiles during Giardia infection and VSP-based vaccination.
    Infect Immun. 2018 Mar 19. pii: IAI.00773-17. doi: 10.1128/IAI.00773.
    PubMed     Text format     Abstract available
    
    
    February 2018
43. OLSEN RW, Ecklu-Mensah G, Bengtsson A, Ofori MF, et al
    Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria.
    Infect Immun. 2018 Feb 5. pii: IAI.00622-17. doi: 10.1128/IAI.00622.
    PubMed     Text format     Abstract available
    
    
    January 2018
44. JONES K, Versteeg L, Damania A, Keegan B, et al
    Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.
    Infect Immun. 2018 Jan 8. pii: IAI.00876-17. doi: 10.1128/IAI.00876.
    PubMed     Text format     Abstract available
    
    
    
45. MARTINEZ-BECERRA FJ, Kumar P, Vishwakarma V, Kim JH, et al
    Characterization and protective efficacy of type three secretion proteins as a broadly protective subunit vaccine against Salmonella enterica serovars.
    Infect Immun. 2018 Jan 8. pii: IAI.00473-17. doi: 10.1128/IAI.00473.
    PubMed     Text format     Abstract available
    
    
    December 2017
46. BROCKMEIER SL, Loving CL, Nicholson TL, Wang J, et al
    Use of proteins identified through a functional genomic screen to develop a protein subunit vaccine that provides significant protection against virulent Streptococcus suis in pigs.
    Infect Immun. 2017 Dec 4. pii: IAI.00559-17. doi: 10.1128/IAI.00559.
    PubMed     Text format     Abstract available
    
    
    
47. PEREZ AC, Johnson A, Chen Z, Wilding GE, et al
    Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.
    Infect Immun. 2017 Dec 4. pii: IAI.00652-17. doi: 10.1128/IAI.00652.
    PubMed     Text format     Abstract available
    
    
    
48. LADDY DJ, Bonavia A, Hanekom WA, Kaushal D, et al
    Toward Tuberculosis Vaccine Development: Recommendations for NHP Study Design.
    Infect Immun. 2017 Dec 4. pii: IAI.00776-17. doi: 10.1128/IAI.00776.
    PubMed     Text format     Abstract available
    
    
    November 2017
49. WANG L, Zhu C, Zhang T, Tian Q, et al
    Non-pathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection.
    Infect Immun. 2017 Nov 13. pii: IAI.00630-17. doi: 10.1128/IAI.00630.
    PubMed     Text format     Abstract available
    
    
    
50. BURTNICK MN, Shaffer TL, Ross BN, Muruato LA, et al
    Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis.
    Infect Immun. 2017 Nov 6. pii: IAI.00724-17. doi: 10.1128/IAI.00724.
    PubMed     Text format     Abstract available
    
    
    October 2017
51. PAL S, Tifrea DF, Zhong G, de la Maza LM, et al
    Transcervical inoculation with Chlamydia trachomatis induces infertility in HLA-DR4-transgenic and wild type mice.
    Infect Immun. 2017 Oct 16. pii: IAI.00722-17. doi: 10.1128/IAI.00722.
    PubMed     Text format     Abstract available
    
    
    
52. PARZYCH EM, Miura K, Ramanathan A, Long CA, et al
    Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.
    Infect Immun. 2017 Oct 9. pii: IAI.00486-17. doi: 10.1128/IAI.00486.
    PubMed     Text format     Abstract available
    
    
    September 2017
53. LACEY KA, Leech JM, Lalor SJ, McCormack N, et al
    The Staphylococcus aureus cell wall-anchored protein clumping factor A is an important T cell antigen.
    Infect Immun. 2017 Sep 25. pii: IAI.00549-17. doi: 10.1128/IAI.00549.
    PubMed     Text format     Abstract available
    
    
    
54. SEVASTSYANOVICH YR, Withers DR, Marriott CL, Morris FC, et al
    Antigen localisation influences the magnitude and kinetics of the endogenous adaptive immune response to recombinant Salmonella vaccines.
    Infect Immun. 2017 Sep 11. pii: IAI.00593-17. doi: 10.1128/IAI.00593.
    PubMed     Text format     Abstract available
    
    
    March 2017
55. LEES JA, Brouwer M, van der Ende A, Parkhill J, et al
    Within-Host Sampling of a Natural Population Shows Signs of Selection on Pde1 during Bacterial Meningitis.
    Infect Immun. 2017;85.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: